世界の内視鏡的逆行性胆道膵管造影市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endoscopic Retrograde Cholangiopancreatography Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2161 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、内視鏡的逆行性胆道膵管造影のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（内視鏡的括約筋切開術、結石・胆道破片除去、胆管ステント挿入、狭窄拡張）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・内視鏡的逆行性胆道膵管造影の市場動向 ・企業の競争状況、市場シェア ・内視鏡的逆行性胆道膵管造影の種類別市場規模（内視鏡的括約筋切開術、結石・胆道破片除去、胆管ステント挿入、狭窄拡張） ・内視鏡的逆行性胆道膵管造影の用途別市場規模（病院、クリニック、その他） ・内視鏡的逆行性胆道膵管造影の北米市場規模2016-2027（アメリカ、カナダ） ・内視鏡的逆行性胆道膵管造影のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・内視鏡的逆行性胆道膵管造影のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・内視鏡的逆行性胆道膵管造影の中南米市場規模2016-2027（メキシコ、ブラジル） ・内視鏡的逆行性胆道膵管造影の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Boston Scientific、Medtronic、CONMED、Stryker、Fujifilm、Ethicon、Becton Dickinson、B.Braun Melsungen、Cook） ・結論

Endoscopic retrograde cholangiopancreatography is a radiologic imaging technique, which is performed by combining both endoscopy and fluoroscopy for the treatment of biliary disorders.
This technique is majorly utilized for the diagnosis of certain disorders associated with pancreatic ductal systems.

Market Analysis and Insights: Global Endoscopic Retrograde Cholangiopancreatography Market
The global Endoscopic Retrograde Cholangiopancreatography market size is projected to reach US$ 21920 million by 2026, from US$ 16150 million in 2019, at a CAGR of 4.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endoscopic Retrograde Cholangiopancreatography market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endoscopic Retrograde Cholangiopancreatography market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endoscopic Retrograde Cholangiopancreatography market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endoscopic Retrograde Cholangiopancreatography market.

Global Endoscopic Retrograde Cholangiopancreatography Scope and Market Size
Endoscopic Retrograde Cholangiopancreatography market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endoscopic Retrograde Cholangiopancreatography market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Endoscopic sphincterotomy
Removal of stones or other biliary debris
Insertion of bile duct stent(s)
Dilation of strictures

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Boston Scientific
Medtronic
CONMED
Stryker
Fujifilm
Ethicon
Becton Dickinson
B.Braun Melsungen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Endoscopic sphincterotomy
1.2.3 Removal of stones or other biliary debris
1.2.4 Insertion of bile duct stent(s)
1.2.5 Dilation of strictures
1.3 Market by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endoscopic Retrograde Cholangiopancreatography Market Perspective (2016-2027)
2.2 Endoscopic Retrograde Cholangiopancreatography Growth Trends by Regions
2.2.1 Endoscopic Retrograde Cholangiopancreatography Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endoscopic Retrograde Cholangiopancreatography Historic Market Share by Regions (2016-2021)
2.2.3 Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Regions (2022-2027)
2.3 Endoscopic Retrograde Cholangiopancreatography Industry Dynamic
2.3.1 Endoscopic Retrograde Cholangiopancreatography Market Trends
2.3.2 Endoscopic Retrograde Cholangiopancreatography Market Drivers
2.3.3 Endoscopic Retrograde Cholangiopancreatography Market Challenges
2.3.4 Endoscopic Retrograde Cholangiopancreatography Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endoscopic Retrograde Cholangiopancreatography Players by Revenue
3.1.1 Global Top Endoscopic Retrograde Cholangiopancreatography Players by Revenue (2016-2021)
3.1.2 Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Players (2016-2021)
3.2 Global Endoscopic Retrograde Cholangiopancreatography Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endoscopic Retrograde Cholangiopancreatography Revenue
3.4 Global Endoscopic Retrograde Cholangiopancreatography Market Concentration Ratio
3.4.1 Global Endoscopic Retrograde Cholangiopancreatography Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endoscopic Retrograde Cholangiopancreatography Revenue in 2020
3.5 Endoscopic Retrograde Cholangiopancreatography Key Players Head office and Area Served
3.6 Key Players Endoscopic Retrograde Cholangiopancreatography Product Solution and Service
3.7 Date of Enter into Endoscopic Retrograde Cholangiopancreatography Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endoscopic Retrograde Cholangiopancreatography Breakdown Data by Type
4.1 Global Endoscopic Retrograde Cholangiopancreatography Historic Market Size by Type (2016-2021)
4.2 Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Type (2022-2027)

5 Endoscopic Retrograde Cholangiopancreatography Breakdown Data by Application
5.1 Global Endoscopic Retrograde Cholangiopancreatography Historic Market Size by Application (2016-2021)
5.2 Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size (2016-2027)
6.2 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type
6.2.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021)
6.2.2 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027)
6.2.3 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2027)
6.3 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application
6.3.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021)
6.3.2 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027)
6.3.3 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2027)
6.4 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country
6.4.1 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021)
6.4.2 North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endoscopic Retrograde Cholangiopancreatography Market Size (2016-2027)
7.2 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type
7.2.1 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021)
7.2.2 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027)
7.2.3 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2027)
7.3 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application
7.3.1 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021)
7.3.2 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027)
7.3.3 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2027)
7.4 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country
7.4.1 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021)
7.4.2 Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size (2016-2027)
8.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type
8.2.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2027)
8.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application
8.3.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2027)
8.4 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region
8.4.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size (2016-2027)
9.2 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type
9.2.1 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021)
9.2.2 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027)
9.2.3 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2027)
9.3 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application
9.3.1 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021)
9.3.2 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027)
9.3.3 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2027)
9.4 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country
9.4.1 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021)
9.4.2 Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size (2016-2027)
10.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type
10.2.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2027)
10.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application
10.3.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2027)
10.4 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country
10.4.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Introduction
11.1.4 Johnson & Johnson Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Introduction
11.2.4 Boston Scientific Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.2.5 Boston Scientific Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Endoscopic Retrograde Cholangiopancreatography Introduction
11.3.4 Medtronic Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.3.5 Medtronic Recent Development
11.4 CONMED
11.4.1 CONMED Company Details
11.4.2 CONMED Business Overview
11.4.3 CONMED Endoscopic Retrograde Cholangiopancreatography Introduction
11.4.4 CONMED Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.4.5 CONMED Recent Development
11.5 Stryker
11.5.1 Stryker Company Details
11.5.2 Stryker Business Overview
11.5.3 Stryker Endoscopic Retrograde Cholangiopancreatography Introduction
11.5.4 Stryker Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.5.5 Stryker Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Details
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Endoscopic Retrograde Cholangiopancreatography Introduction
11.6.4 Fujifilm Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.6.5 Fujifilm Recent Development
11.7 Ethicon
11.7.1 Ethicon Company Details
11.7.2 Ethicon Business Overview
11.7.3 Ethicon Endoscopic Retrograde Cholangiopancreatography Introduction
11.7.4 Ethicon Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.7.5 Ethicon Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Details
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Introduction
11.8.4 Becton Dickinson Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.8.5 Becton Dickinson Recent Development
11.9 B.Braun Melsungen
11.9.1 B.Braun Melsungen Company Details
11.9.2 B.Braun Melsungen Business Overview
11.9.3 B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Introduction
11.9.4 B.Braun Melsungen Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.9.5 B.Braun Melsungen Recent Development
11.10 Cook
11.10.1 Cook Company Details
11.10.2 Cook Business Overview
11.10.3 Cook Endoscopic Retrograde Cholangiopancreatography Introduction
11.10.4 Cook Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
11.10.5 Cook Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endoscopic Retrograde Cholangiopancreatography Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Endoscopic sphincterotomy
Table 3. Key Players of Removal of stones or other biliary debris
Table 4. Key Players of Insertion of bile duct stent(s)
Table 5. Key Players of Dilation of strictures
Table 6. Global Endoscopic Retrograde Cholangiopancreatography Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endoscopic Retrograde Cholangiopancreatography Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endoscopic Retrograde Cholangiopancreatography Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Regions (2016-2021)
Table 10. Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Regions (2022-2027)
Table 12. Endoscopic Retrograde Cholangiopancreatography Market Trends
Table 13. Endoscopic Retrograde Cholangiopancreatography Market Drivers
Table 14. Endoscopic Retrograde Cholangiopancreatography Market Challenges
Table 15. Endoscopic Retrograde Cholangiopancreatography Market Restraints
Table 16. Global Endoscopic Retrograde Cholangiopancreatography Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Players (2016-2021)
Table 18. Global Top Endoscopic Retrograde Cholangiopancreatography Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endoscopic Retrograde Cholangiopancreatography as of 2020)
Table 19. Ranking of Global Top Endoscopic Retrograde Cholangiopancreatography Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endoscopic Retrograde Cholangiopancreatography Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endoscopic Retrograde Cholangiopancreatography Product Solution and Service
Table 23. Date of Enter into Endoscopic Retrograde Cholangiopancreatography Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type (2016-2021)
Table 27. Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endoscopic Retrograde Cholangiopancreatography Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Application (2016-2021)
Table 31. Global Endoscopic Retrograde Cholangiopancreatography Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Product
Table 66. Johnson & Johnson Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Boston Scientific Company Details
Table 69. Boston Scientific Business Overview
Table 70. Boston Scientific Endoscopic Retrograde Cholangiopancreatography Product
Table 71. Boston Scientific Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 72. Boston Scientific Recent Development
Table 73. Medtronic Company Details
Table 74. Medtronic Business Overview
Table 75. Medtronic Endoscopic Retrograde Cholangiopancreatography Product
Table 76. Medtronic Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 77. Medtronic Recent Development
Table 78. CONMED Company Details
Table 79. CONMED Business Overview
Table 80. CONMED Endoscopic Retrograde Cholangiopancreatography Product
Table 81. CONMED Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 82. CONMED Recent Development
Table 83. Stryker Company Details
Table 84. Stryker Business Overview
Table 85. Stryker Endoscopic Retrograde Cholangiopancreatography Product
Table 86. Stryker Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 87. Stryker Recent Development
Table 88. Fujifilm Company Details
Table 89. Fujifilm Business Overview
Table 90. Fujifilm Endoscopic Retrograde Cholangiopancreatography Product
Table 91. Fujifilm Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 92. Fujifilm Recent Development
Table 93. Ethicon Company Details
Table 94. Ethicon Business Overview
Table 95. Ethicon Endoscopic Retrograde Cholangiopancreatography Product
Table 96. Ethicon Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 97. Ethicon Recent Development
Table 98. Becton Dickinson Company Details
Table 99. Becton Dickinson Business Overview
Table 100. Becton Dickinson Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 101. Becton Dickinson Recent Development
Table 102. B.Braun Melsungen Company Details
Table 103. B.Braun Melsungen Business Overview
Table 104. B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Product
Table 105. B.Braun Melsungen Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 106. B.Braun Melsungen Recent Development
Table 107. Cook Company Details
Table 108. Cook Business Overview
Table 109. Cook Endoscopic Retrograde Cholangiopancreatography Product
Table 110. Cook Revenue in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021) & (US$ Million)
Table 111. Cook Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Type: 2020 VS 2027
Figure 2. Endoscopic sphincterotomy Features
Figure 3. Removal of stones or other biliary debris Features
Figure 4. Insertion of bile duct stent(s) Features
Figure 5. Dilation of strictures Features
Figure 6. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Endoscopic Retrograde Cholangiopancreatography Report Years Considered
Figure 11. Global Endoscopic Retrograde Cholangiopancreatography Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endoscopic Retrograde Cholangiopancreatography Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Regions: 2020 VS 2027
Figure 14. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Regions (2022-2027)
Figure 15. Global Endoscopic Retrograde Cholangiopancreatography Market Share by Players in 2020
Figure 16. Global Top Endoscopic Retrograde Cholangiopancreatography Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endoscopic Retrograde Cholangiopancreatography as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endoscopic Retrograde Cholangiopancreatography Revenue in 2020
Figure 18. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type (2016-2021)
Figure 19. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type (2022-2027)
Figure 20. North America Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endoscopic Retrograde Cholangiopancreatography Market Share by Type (2016-2027)
Figure 22. North America Endoscopic Retrograde Cholangiopancreatography Market Share by Application (2016-2027)
Figure 23. North America Endoscopic Retrograde Cholangiopancreatography Market Share by Country (2016-2027)
Figure 24. United States Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endoscopic Retrograde Cholangiopancreatography Market Share by Type (2016-2027)
Figure 28. Europe Endoscopic Retrograde Cholangiopancreatography Market Share by Application (2016-2027)
Figure 29. Europe Endoscopic Retrograde Cholangiopancreatography Market Share by Country (2016-2027)
Figure 30. Germany Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Share by Region (2016-2027)
Figure 40. China Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endoscopic Retrograde Cholangiopancreatography Market Share by Type (2016-2027)
Figure 48. Latin America Endoscopic Retrograde Cholangiopancreatography Market Share by Application (2016-2027)
Figure 49. Latin America Endoscopic Retrograde Cholangiopancreatography Market Share by Country (2016-2027)
Figure 50. Mexico Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Share by Country (2016-2027)
Figure 56. Turkey Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endoscopic Retrograde Cholangiopancreatography Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 60. Boston Scientific Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 62. CONMED Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 63. Stryker Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 64. Fujifilm Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 65. Ethicon Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 66. Becton Dickinson Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 67. B.Braun Melsungen Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 68. Cook Revenue Growth Rate in Endoscopic Retrograde Cholangiopancreatography Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---